You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 154 No. 13, 11 July 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Long-term Efficacy of Intranasal Mupirocin Ointment

A Prospective Cohort Study of Staphylococcus aureus Carriage

Bradley N. Doebbeling, MD, MS; David R. Reagan, MD, PhD; Michael A. Pfaller, MD; Alison K. Houston; Richard J. Hollis, MA; Richard P. Wenzel, MD, MSc

Arch Intern Med. 1994;154(13):1505-1508.


Abstract

Background
We investigated the long-term effect of a single 5-day application of intranasal mupirocin calcium ointment on Staphylococcus aureus nasal and hand colonization. The subjects were 68 healthy volunteers who were health care workers with stable S aureus nasal carriage and who had participated in a randomized, double-blind, placebo-controlled clinical trial of intranasal mupirocin ointment.

Methods
A 1-year prospective cohort study of S aureus nasal carriers after treatment with active drug or placebo was performed. Cultures were obtained from all subjects 6 and 12 months after therapy. All subjects returned for the 6-month visit; 63 (93%) were examined at 1 year. The major outcome measure was the relative proportion of any S aureus cultured at either site at 6 and 12 months. The S aureus isolates were typed by restriction endonuclease analysis of plasmid DNA and by antibiotic susceptibility tests; the similarity of nasal and hand isolate "fingerprints" was compared.

Results
At 6 months, nasal carriage was 48% in the treatment group vs 72% in controls (relative risk, 0.68; 95% confidence interval, 0.45 to 1.02; P=.054); at 1 year, nasal carriage was 53% vs 76%, respectively (relative risk, 0.70; 95% confidence interval, 0.48 to 1.02; P=.056). Hand carriage at 6 months was significantly reduced among mupirocin recipients relative to controls (15% and 48%; P=.04, adjusted for the baseline rate of hand carriage). Thirty-six percent of treated subjects were recolonized in the nares with a new strain at 1 year, whereas 34% had reisolation of the original strain after initially negative posttherapy cultures. During the year of follow-up, hand carriage was observed at least once in two thirds of the subjects. Nearly all of the hand isolates (87%) exactly matched the subjects' coincident nasal plasmid fingerprint and antibiogram type.

Conclusions
A single brief treatment course of intranasal mupirocin was effective in reducing nasal S aureus carriage for up to 1 year. When S aureus was recovered after nasal decolonization, the new isolate was as likely to represent colonization with a new strain as reisolation of the original strain. Staphylococcus aureus hand carriage was significantly decreased 6 months after therapy, further implicating the nares as the primary reservoir site for hand carriage.

(Arch Intern Med. 1994;154:1505-1508)



Author Affiliations

From the University of Iowa College of Medicine (Drs Doebbeling, Reagan, Pfaller, and Wenzel, Ms Houston, and Mr Hollis); Department of Veterans Affairs Medical Center (Dr Doebbeling); and University of Iowa Hospitals and Clinics, Iowa City (Drs Pfaller and Wenzel). Dr Reagan is now with James H. Quillen College of Medicine, East Tennessee State University, Johnson City.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects
Coates et al.
J Antimicrob Chemother 2009;64:9-15.
ABSTRACT | FULL TEXT  

Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian Hospitals
Simor et al.
Antimicrob. Agents Chemother. 2007;51:3880-3886.
ABSTRACT | FULL TEXT  

Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial
Ellis et al.
Antimicrob. Agents Chemother. 2007;51:3591-3598.
ABSTRACT | FULL TEXT  

Development and Characterization of a Staphylococcus aureus Nasal Colonization Model in Mice
Kiser et al.
Infect. Immun. 1999;67:5001-5006.
ABSTRACT | FULL TEXT  

Risk Factors for Hospital-Acquired Staphylococcus aureus Bacteremia
Jensen et al.
Arch Intern Med 1999;159:1437-1444.
ABSTRACT | FULL TEXT  

A 1-Year Trial of Nasal Mupirocin in the Prevention of Recurrent Staphylococcal Nasal Colonization and Skin Infection
Raz et al.
Arch Intern Med 1996;156:1109-1112.
ABSTRACT  

Mupirocin Calcium Ointment for Long-term Eradication of S. aureus Nasal Carriage
Journal Watch Dermatology 1994;1994:1-1.
FULL TEXT  

NASAL MUPIROCIN OINTMENT FOR S. AUREUS CARRIAGE
JWatch General 1994;1994:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.